EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Keith B Allen
Robert D Dowling
David A Heimansohn
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allen, K. B
Right arrow Articles by Shaar, C. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allen, K. B
Right arrow Articles by Shaar, C. J

Eur J Cardiothorac Surg 1998;14:S100-S104
© 1998 Elsevier Science NL

Transmyocardial revascularization utilizing a holmium:YAG Laser 1

Keith B Allena,*, Robert D Dowlingb, David A Heimansohna, Eileen Reitsmaa, Luanne Didelotb, Carl J Shaara

a Department of Cardiovascular/Thoracic Surgery, St. Vincent Hospital and Health Care Center Indianapolis, IN, USA
b Department of Cardiovascular/Thoracic Surgery, University of Louisville, Louisville, KY, USA

* Corresponding author. 8333 Naab Road, Suite 300, Indianapolis, IN 46260. Tel.: +1 317 3383551; fax: +1 317 3389209.

Objective: To evaluate the efficacy of transmyocardial revascularization performed on patients with refractory class IV or unstable angina with a holmium:yttrium-aluminum-garnet laser. Methods: Transmyocardial revascularization with a holmium:yttrium-aluminum-garnet laser was performed in 42 patients with refractory angina who were not candidates for percutaneous transluminal coronary angioplasty or coronary artery bypass grafting. Patients had either Canadian Heart Association class IV angina (n=23) or unstable angina (n=19) and were unable to be weaned from intravenous nitroglycerin. Preoperative thallium studies identified the extent and location of reversible ischemia. Operative exposure was via a limited left anterior thoracotomy. An average of 45±11 laser channels were created with a mean operative time of 106±38 min. Results: Perioperative mortality was 12% (5/42) with no late deaths. Complications included ventricular 7.1%(3/42) and atrial 4.7% (2/42) arrhythmias, reoperation for chest-wall hemorrhage 2% (1/42), and respiratory failure requiring reintubation 2% (1/42). Intra-aortic balloon pump placement was required in 12% (5/42). The mean postoperative length of stay was 5.5±4.9 (1–25) days. Mean follow-up on 100% of patients is 5.4±3.0 (1–12) months. At 3 (n=33) and 6 (n=21) months follow-up the mean angina class was 1.5±0.1 (P<0.002) and 1.1±0.1 (P<0.001), respectively. Conclusions: Transmyocardial revascularization utilizing a holmium:yttrium-aluminum-garnet laser resulted in a significant reduction in angina class and was beneficial in patients with refractory angina untreatable by conventional methods.

Key Words: Transmyocardial revascularization • Holmium:YAG Laser • Laser surgery




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Tasse and R. Arora
Transmyocardial Revascularization: Peril and Potential
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 44 - 53.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. B. Allen, R. D. Dowling, W. W. Angell, D. M. Gangahar, T. L. Fudge, W. Richenbacher, S. L. Selinger, M. R. Petracek, and D. Murphy
Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial
Ann. Thorac. Surg., April 1, 2004; 77(4): 1228 - 1234.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Loubani, D. Chin, J. N. Leverment, and M. Galinanes
Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass
Ann. Thorac. Surg., October 1, 2003; 76(4): 1163 - 1166.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. De Carlo, A. D. Milano, S. Pratali, M. Levantino, R. Mariotti, and U. Bortolotti
Symptomatic improvement after transmyocardial laser revascularization: how long does it last?
Ann. Thorac. Surg., September 1, 2000; 70(3): 1130 - 1133.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. B. Allen, R. D. Dowling, T. L. Fudge, G. P. Schoettle, S. L. Selinger, D. M. Gangahar, W. W. Angell, M. R. Petracek, C. J. Shaar, and W. W. O'Neill
Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory Angina
N. Engl. J. Med., September 30, 1999; 341(14): 1029 - 1036.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.